CD Buzz Video

Geltor: one biotech company, two proteins, and an entirely new generation of skin care

By Deanna Utroske contact

- Last updated on GMT

Biotechnology takes advantage of two truths, DNA coding and micro-organisms’ innate ability to ingest one item and generate another. It is the subsequent corollary with which biotech companies like Geltor manufacture bioidentical ingredients—in this case collagens—that are making a world of difference in the beauty industry.

Indeed in the consumer landscape, Geltor is banking on the fact that biotech, while relatively new, is a fairly simple scientific reality.

Consumers “understand biotechnology,” ​acknowledges Geltor Co-Founder and CEO Alex Lorestani. And he goes on to note in this video interview with Cosmetics Design editor Deanna Utroske, that “the [Geltor ingredient] story is so much more intuitive to customers than we had imagined….and the thing that really shines through is…biocompatibility.”

The science, ingredients, and production processes that go into modern-day skin care are no mystery to today’s curious and well-educated consumers. (Yes, misinformation persists; but it is not the premise from which innovative ingredient makers and brands operate.)

At in-cosmetics Global in Paris this year, Geltor showcased its second ingredient, HumaColl21—a bioidentical human collagen protein, which Lorestani describes as “the world’s first, clinically proven, designer human collagen ingredient.”

He talks with Cosmetics Design about the first skin care product on the market formulated with HumaColl21, why his company seeks out third-party cruelty-free and Halal certifications, how his team sorts through all the possible collagen proteins to select and produce those that will best benefit beauty makers and end consumers, and much more.

Watch the full interview above to learn more about HumaColl21 and Geltor more broadly.

---

DeannaUtroske_Editor_CosmeticsDesign

Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related news

Related products

show more

LACTOSPORIN®: A NOVEL COSMECEUTICAL POSTBIOTIC

LACTOSPORIN®: A NOVEL COSMECEUTICAL POSTBIOTIC

SABINSA | 06-Sep-2019 | Data Sheet

Patented technology yields the novel probiotic metabolite, LactoSporin®. Derived from Bacillus coagulans MTCC 5856, but with no live cells, LactoSporin...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars